Bendre_2023_Pharmaceuticals.(Basel)_16_798

Reference

Title : Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging - Bendre_2023_Pharmaceuticals.(Basel)_16_798
Author(s) : Bendre S , Kuo HT , Merkens H , Zhang Z , Wong A , Benard F , Lin KS
Ref : Pharmaceuticals (Basel) , 16 :798 , 2023
Abstract : Bendre_2023_Pharmaceuticals.(Basel)_16_798
ESTHER : Bendre_2023_Pharmaceuticals.(Basel)_16_798
PubMedSearch : Bendre_2023_Pharmaceuticals.(Basel)_16_798
PubMedID: 37375746

Related information

Citations formats

Bendre S, Kuo HT, Merkens H, Zhang Z, Wong A, Benard F, Lin KS (2023)
Synthesis and Preclinical Evaluation of Novel (68)Ga-Labeled (R)-Pyrrolidin-2-yl-boronic Acid-Based PET Tracers for Fibroblast Activation Protein-Targeted Cancer Imaging
Pharmaceuticals (Basel) 16 :798

Bendre S, Kuo HT, Merkens H, Zhang Z, Wong A, Benard F, Lin KS (2023)
Pharmaceuticals (Basel) 16 :798